Endo, Inc.: Endo Launches Doxycycline for Injection, USP
Endo, Inc. (OTCQX: NDOI) announced today that it has begun shipping doxycycline for injection, USP 100 mg/vial, an AP-rated version of DOXY 100. "We're ...
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
Endo, Inc. (OTCQX: NDOI) announced today that the U.S. Food and Drug Administration (FDA) has approved commercial production ...